MDY Mdy Healthcare

RNS No 9743w
MEDISYS PLC
14th December 1998

                                       
                    APPOINTMENT OF CHIEF FINANCIAL OFFICER

Medisys PLC ("Medisys"), a leading provider of diagnostic, medical and  safety
products,  announces  the  appointment of Michael  Barry  as  Chief  Financial
Officer and to the board of directors effective 18 January 1999.

Mr.  Barry  spent eight years (1988 to 1996) in a number of senior  management
positions  at  Elan  Corporation,  plc, the  leading  Irish  drug  development
company,  which is listed on the New York, London and Dublin Stock  Exchanges.
He  was  appointed  Group  Vice President Finance in  1988.   In  addition  to
participating  in  numerous  public financings,  he  established  and  managed
financial  reporting  systems.   In  1995, he  was  appointed  Corporate  Vice
President  and Head of Pharmaceutical Operations with responsibility  for  the
general  management  of  Elan's  two  principal  pharmaceutical  manufacturing
plants,  one in Athlone, Ireland and the other in the US with combined  annual
sales of approximately $60 million.

In  mid  1996,  Mr.  Barry  became finance director of  Fountainhead  Holdings
Limited, the holding company that manages the business interests of Dr. Donald
E. Panoz, the founder and former Chairman and Chief Executive Officer of Elan.
In  this  role, Mr. Barry oversaw financial operations and negotiated business
relationships for Dr. Panoz's varied interests.  Dr. Panoz has been  a  member
of  the  Medisys  board since May 1998.  Mr. Barry, aged  41,  trained  as  an
accountant  at Price Waterhouse.  Brian Timmons, the current Finance  Director
of Medisys, will leave in 1999 to pursue other interests.

Commenting on the appointment, Kurt E. Amundson, President and Chief Operating
Officer of Medisys, said:

"Michael  brings  with him a wealth of industry as well  as  general  business
experience,  particularly in financial structuring and  reporting  which  will
help  support  Medisys  in its growth.  We want to thank  Brian  Timmons,  the
current  Finance Director, for his contributions and efforts in the  formation
and early stage development of Medisys."

Following  Medisys' recent successful #15 million convertible  bond  offering,
led by Nomura International, the acquisition of Lukens Medical Corporation has
now  been  completed.  The Medisys group now consists of  two  core  operating
divisions, a diagnostics division and a medical supplies and safety division.

Enquiries:

Medisys PLC
Kurt Amundson, President & Chief Operating Officer     Tel: 001 650 327 7900

Gavin Anderson & Company
David Yates/Sophie Pender-Cudlip                       Tel: 0171 457 2345


END

BOAVFFFFVLKZFKV

MDY Healthcare (LSE:MDY)
Historical Stock Chart
Von Jun 2024 bis Jul 2024

MDY Healthcare (LSE:MDY)
Historical Stock Chart
Von Jul 2023 bis Jul 2024